Septerna (SEPN) Net Cash Flow (2023 - 2026)
Septerna's (SEPN) quarterly Net Cash Flow came in at -$49.1 million in Q1 2026, down 74.48% year-on-year from -$192.4 million in Q1 2025, and up 75.35% quarter-over-quarter from -$199.3 million in Q4 2025.
Septerna (SEPN) Net Cash Flow (2023 - 2026) Analysis & Trends
Septerna's Net Cash Flow history runs 4 years deep, the most recent figure standing at -$49.1 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 74.48% year-over-year to -$49.1 million in Q1 2026; TTM through Mar 2026 was -$138.4 million, a 357.55% decrease from a year earlier, with the FY2025 full-year figure at -$117.5 million, down 178.47% from the prior year.
- Net Cash Flow rose to -$49.1 million in Q1 2026 per SEPN's latest filing, from -$199.3 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $150.0 million in Q4 2024 and bottomed at -$199.3 million in Q4 2025.
- The 4-year median for Net Cash Flow is -$22.9 million (2024), against an average of -$10.2 million.
- Across the five-year window, Net Cash Flow jumped 1594.16% in 2024 and sank 294.11% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at -$10.0 million in 2023, then soared by 1594.16% to $150.0 million in 2024, then sank by 232.89% to -$199.3 million in 2025, then surged by 75.35% to -$49.1 million in 2026.
- Per Business Quant, the three latest SEPN Net Cash Flow figures stand at -$49.1 million (Q1 2026), -$199.3 million (Q4 2025), and $130.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | -49.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.12 Mn |
| Mar 31, 2026 | -49.12 Mn |
| Dec 31, 2025 | -199.27 Mn |
| Dec 31, 2025 | -199.27 Mn |
| Sep 30, 2025 | 130.68 Mn |
| Sep 30, 2025 | 130.68 Mn |
| Jun 30, 2025 | -20.73 Mn |
| Jun 30, 2025 | -20.73 Mn |
| Mar 31, 2025 | -28.15 Mn |
| Mar 31, 2025 | -28.15 Mn |
| Dec 31, 2024 | 149.95 Mn |
| Dec 31, 2024 | 149.95 Mn |
| Sep 30, 2024 | -42.93 Mn |
| Sep 30, 2024 | -42.93 Mn |
| Jun 30, 2024 | -25.12 Mn |
| Jun 30, 2024 | -25.12 Mn |
| Mar 31, 2024 | -7.14 Mn |
| Mar 31, 2024 | -7.14 Mn |
| Dec 31, 2023 | -10.04 Mn |
| Dec 31, 2023 | -10.04 Mn |